Reference : Once weekly recombinant human erythropoietin therapy is very efficient after allogene...
Scientific journals : Article
Human health sciences : Hematology
http://hdl.handle.net/2268/6293
Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment.
English
Baron, Frédéric mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
Frere, Pascale mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
Beguin, Yves mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie clinique >]
2003
Haematologica
Ferrata Storti Foundation
88
6
718-20
Yes (verified by ORBi)
International
0390-6078
1592-8721
Pavia
Italy
[en] Adolescent ; Adult ; Child ; Child, Preschool ; Combined Modality Therapy ; Drug Administration Schedule ; Erythropoietin/biosynthesis ; Erythropoietin, Recombinant/administration & dosage/therapeutic use ; Female ; Hemoglobins/analysis ; Humans ; Kinetics ; Male ; Middle Aged ; Peripheral Blood Stem Cell Transplantation ; Transplantation, Homologous ; Treatment Outcome
http://hdl.handle.net/2268/6293

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Epo-rHuEpo postgreffe TIW vs QW.Haematologica.pdfPublisher postprint78.23 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.